Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

NCT02288273 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Bydureon
DRUG: Placebo

Sponsor

AstraZeneca